Strides Pharma gets USFDA nod for Ursodiol tablets, a liver disease treatment drug

Strides Pharma Science gets an approval from the USFDA to market Ursodiol tablets used for treating primary biliary cirrhosis, a progressive disease of the liver caused by a buildup of bile within the liver.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news